My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

123.65 +1.42 (+1.16%)
Official Closing Price Updated: 7:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 915,203
Open 123.00
Bid (Size) 120.69 (1)
Ask (Size) 130.00 (1)
Prev. Close 122.23
Today's Range 122.78 - 123.86
52wk Range 96.06 - 130.46
Shares Outstanding N/A
Dividend Yield 3.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharma Tariffs Back In Spotlight On New Trump Threat
President Donald Trump threatened 100% tariffs on some drug imports. 
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de 
Via Benzinga
Topics Government World Trade

Performance

YTD
+27.3%
+27.3%
1 Month
-2.6%
-2.6%
3 Month
+3.0%
+3.0%
6 Month
+9.8%
+9.8%
1 Year
+7.0%
+7.0%

More News

Read More
Trump's New Tariff Barrage Targets Drugs, Trucks, Cabinets: President Says Move Will Protect Manufacturers From 'Unfair Outside Competition'
Via Benzinga
Topics Government World Trade
Monte Rosa Therapeutics Stock Scores Biggest Gain In Nearly A Year On $5.7B Novartis Deal For Immune-Mediated Diseases
Via Stocktwits
Google DeepMind Chief Eyes Radical AI-Powered Shift In Drug Discovery Speed — Eli Lilly, Novartis Are Already Onboard
Via Stocktwits
Why Is Avidity Biosciences Stock Down 20% Pre-market Today?
Via Stocktwits
Eli Lilly Stock Is Trading Down Thursday: What's Behind The Move?
Via Benzinga
AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection
Via MarketMinute
Topics Artificial Intelligence
Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch
Via Benzinga
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened
Via Stocktwits
Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies
Via Benzinga
Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection
Via Benzinga
Roche Targets Top Spot In Weight Loss Drug Market
Via Benzinga
Novartis Builds US Drug Reserves Against Potential Tariffs
Via Benzinga
Topics World Trade
Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
Via MarketMinute
Topics Animal Testing Artificial Intelligence Intellectual Property
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
Via MarketMinute
Monte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease Treatments
Via Benzinga
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Value Investors
Via Chartmill
This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark
Via Chartmill
Topics Economy
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz
Via Benzinga
Topics ETFs Government
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
Via Investor's Business Daily
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion
Via Investor's Business Daily
Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
Via MarketBeat
Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition
Via Benzinga

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 123.65
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/26/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.